Use of palliative care, oxygen therapy increasing for COPD

Use of palliative care, oxygen therapy increasing for COPD
(HealthDay)—For patients with advanced chronic obstructive pulmonary disease (COPD), the use of formal palliative care services and long-term oxygen therapy has increased but remains low, according to a study published online June 11 in the American Journal of Respiratory and Critical Care Medicine.

Andrea S. Gershon, M.D., from Sunnybrook Health Sciences Centre in Toronto, and colleagues described trends in use of end-of-life care strategies by people with advanced COPD. The annual proportions of individuals who received formal palliative care, long-term oxygen therapy, or opioids from 2004 to 2014 were ascertained.

A total of 151,912 individuals with advanced COPD were identified in Ontario between 2004 and 2014. The researchers found that there was a 1 percent increase per year in the use of formal , from 5.3 percent in 2004 to 14.3 percent in 2014 (P for trend < 0.001); use of long-term oxygen therapy increased 1.1 percent per year, from 26.4 percent in 2004 to 35.3 percent in 2013 (P for trend < 0.001). Opioid use remained stable (40 percent in 2004 and 41.8 percent in 2014; P for = 0.08). The likelihood of using formal palliative care services and long-term oxygen therapy was lower among younger individuals.

"Efforts should focus on increasing access to such strategies as well as educating patients and providers of their benefits," the authors write.


Explore further

Palliative care reduces odds of suicide in lung cancer patients

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: Use of palliative care, oxygen therapy increasing for COPD (2018, July 2) retrieved 20 May 2019 from https://medicalxpress.com/news/2018-07-palliative-oxygen-therapy-copd.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more